Syndax Pharmaceuticals, Inc. (SNDX) Shareholders’ equity 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) shareholders’ equity at each fiscal year-end, per SEC filings.
$64.6MFY2025 · since FY2016: $84.1M → $64.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $64.6M | -77.6% |
| FY2024 | $288.1M | -48.0% |
| FY2023 | $554.2M | +18.6% |
| FY2022 | $467.4M | +14.5% |
| FY2021 | $408.4M | +61.9% |
| FY2020 | $252.2M | +698.1% |
| FY2019 | $31.6M | -40.4% |
| FY2018 | $53.0M | -49.1% |
| FY2017 | $104.3M | +24.0% |
| FY2016 | $84.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice